To amend the Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2026, to delay the implementation of amendments made by such Act to the hemp production provisions of the Agricultural Marketing Act of 1946.

HR7010 proposes to delay the implementation of amendments to the hemp production provisions of the Agricultural Marketing Act of 1946. This means the current regulatory framework for hemp production, established under the 2018 Farm Bill, remains in place for an extended period. This delay provides stability for companies currently operating within the hemp industry, as they avoid immediate adaptation to new rules. It also postpones any potential market shifts that new regulations might have introduced, such as changes in permissible THC levels or cultivation requirements. There is no direct funding or appropriation associated with this bill. Its impact is purely regulatory, affecting the operational landscape for hemp producers and processors. Companies involved in the cultivation, processing, and distribution of hemp-derived products, including CBD, will continue to operate under familiar guidelines. This avoids compliance costs associated with new regulations but also delays any benefits or drawbacks new regulations might have brought. No specific companies are positioned to receive direct contracts or grants from this bill. Historically, regulatory delays in agricultural sectors often lead to market stability rather than significant price movements. For example, when the 2014 Farm Bill introduced initial hemp pilot programs, the market saw gradual growth as states established their programs, rather than immediate surges. Similarly, the passage of the 2018 Farm Bill, which legalized industrial hemp, led to a boom in the CBD market over the subsequent years, but the immediate market reaction to the bill's passage itself was not a sharp, single-day event. A delay in regulatory changes typically means the status quo persists, preventing both immediate gains from new opportunities and immediate losses from new restrictions. Specific winners are existing hemp producers and processors who benefit from regulatory certainty, such as Charlotte's Web Holdings ($CWBHF) and Green Thumb Industries ($GTBIF), which have established operations under current rules. They avoid the costs and uncertainties of adapting to new regulations. There are no clear losers, as the bill simply delays changes, preventing any immediate negative impacts from new regulations. Companies that might have been poised to capitalize on specific new regulations are simply put on hold. This bill has been referred to the House Committee on Agriculture. The next step is for the committee to consider the bill. If it passes committee, it would then move to the House floor for a vote. Given it is a delay bill, its passage is often less contentious than bills introducing new regulations. The timeline for passage is uncertain but could occur within the current legislative session if there is broad agreement to maintain the current hemp regulatory environment.